We hypothesize that, even with the small number of samples used (randomized selection), there is strong evidence that the selected genes, HOXC6, HOXC8, RARβ, BCL2, and E6/E7, can be used as a pan early cervical adenocarcinoma test. This evidence concerns the gene RARB and cervical adenocarcinoma.